Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
1(8%)
Results Posted
17%(1 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_2
1
8%
Ph early_phase_1
1
8%
Ph not_applicable
8
67%
Ph phase_3
2
17%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution12 total trials
Early Phase 1First-in-human
1(8.3%)
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
2(16.7%)
N/ANon-phased studies
8(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(6)
Terminated(2)
Other(2)

Detailed Status

Completed6
unknown2
Terminated1
Withdrawn1
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
85.7%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (8.3%)
Phase 21 (8.3%)
Phase 32 (16.7%)
N/A8 (66.7%)

Trials by Status

completed650%
terminated18%
withdrawn18%
unknown217%
recruiting18%
not_yet_recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
OTHER
Total Trials
12